Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Study of Once-Daily Oral DFP-11207 in Patients With Solid Tumors

Next Previous
Trial Profile

A Phase I Study of Once-Daily Oral DFP-11207 in Patients With Solid Tumors

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DFP 11207 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Delta-Fly Pharma

    • Most Recent Events

    • 04 Jun 2019 Pharmacokinetic and safety results presented at the 55th Annual Meeting of the American Society of Clinical Oncology.
    • 25 Jan 2019 Status changed from recruiting to completed.
    • 08 Dec 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top